$MMSI
MERIT MEDICAL SYSTEMS INC

2021 Q1 Form 10-Q Financial Statement

#000085698221000012 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $248.9M $243.5M
YoY Change 2.21% 2.17%
Cost Of Revenue $137.0M $139.7M
YoY Change -1.95% 4.51%
Gross Profit $111.9M $103.8M
YoY Change 7.81% -0.81%
Gross Profit Margin 44.95% 42.62%
Selling, General & Admin $81.02M $78.81M
YoY Change 2.81% 0.69%
% of Gross Profit 72.41% 75.93%
Research & Development $16.27M $14.87M
YoY Change 9.43% -7.3%
% of Gross Profit 14.54% 14.33%
Depreciation & Amortization $21.40M $23.32M
YoY Change -8.23% 4.35%
% of Gross Profit 19.13% 22.47%
Operating Expenses $97.70M $102.4M
YoY Change -4.61% 7.68%
Operating Profit $14.19M $1.362M
YoY Change 942.14% -85.7%
Interest Expense $1.537M $3.144M
YoY Change -51.11% 13.75%
% of Operating Profit 10.83% 230.84%
Other Income/Expense, Net -$1.500M -$3.354M
YoY Change -55.28% 25.29%
Pretax Income $12.69M -$1.992M
YoY Change -737.25% -129.1%
Income Tax $1.736M $1.162M
% Of Pretax Income 13.68%
Net Earnings $10.96M -$3.154M
YoY Change -447.43% -150.91%
Net Earnings / Revenue 4.4% -1.3%
Basic Earnings Per Share $0.20 -$0.06
Diluted Earnings Per Share $0.19 -$0.06
COMMON SHARES
Basic Shares Outstanding 55.72M 55.25M
Diluted Shares Outstanding 56.98M 55.25M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.50M $50.10M
YoY Change 16.77% 1.21%
Cash & Equivalents $58.52M $50.08M
Short-Term Investments
Other Short-Term Assets $17.30M $19.80M
YoY Change -12.63% 33.78%
Inventory $200.3M $227.8M
Prepaid Expenses
Receivables $150.3M $150.1M
Other Receivables $12.10M $14.80M
Total Short-Term Assets $438.5M $462.5M
YoY Change -5.19% 9.66%
LONG-TERM ASSETS
Property, Plant & Equipment $378.2M $384.9M
YoY Change -1.74% 12.94%
Goodwill $362.5M $352.2M
YoY Change 2.91% 5.16%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $37.29M $36.57M
YoY Change 1.96% -39.1%
Total Long-Term Assets $1.213B $1.287B
YoY Change -5.71% 1.48%
TOTAL ASSETS
Total Short-Term Assets $438.5M $462.5M
Total Long-Term Assets $1.213B $1.287B
Total Assets $1.652B $1.749B
YoY Change -5.58% 3.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.00M $56.00M
YoY Change -5.36% 8.32%
Accrued Expenses $132.2M $87.10M
YoY Change 51.76% -4.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $7.500M $7.500M
YoY Change 0.0% -65.91%
Total Short-Term Liabilities $207.7M $165.3M
YoY Change 25.64% -7.38%
LONG-TERM LIABILITIES
Long-Term Debt $312.9M $438.1M
YoY Change -28.59% 20.97%
Other Long-Term Liabilities $33.76M $70.89M
YoY Change -52.38% 13.68%
Total Long-Term Liabilities $346.6M $509.0M
YoY Change -31.9% 19.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $207.7M $165.3M
Total Long-Term Liabilities $346.6M $509.0M
Total Liabilities $675.0M $809.5M
YoY Change -16.61% 7.98%
SHAREHOLDERS EQUITY
Retained Earnings $368.8M $364.5M
YoY Change 1.17% -1.41%
Common Stock $615.1M $590.1M
YoY Change 4.24% 2.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $976.7M $939.8M
YoY Change
Total Liabilities & Shareholders Equity $1.652B $1.749B
YoY Change -5.58% 3.52%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $10.96M -$3.154M
YoY Change -447.43% -150.91%
Depreciation, Depletion And Amortization $21.40M $23.32M
YoY Change -8.23% 4.35%
Cash From Operating Activities $35.23M $28.86M
YoY Change 22.06% 113.73%
INVESTING ACTIVITIES
Capital Expenditures $6.171M $13.95M
YoY Change -55.76% -23.58%
Acquisitions $358.0K
YoY Change
Other Investing Activities $500.0K $300.0K
YoY Change 66.67% -115.79%
Cash From Investing Activities -$6.348M -$14.76M
YoY Change -57.0% -29.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.520M $1.261M
YoY Change 337.75% -27.24%
Debt Paid & Issued, Net $40.57M $24.54M
YoY Change 65.32% -54.66%
Cash From Financing Activities -26.25M -6.234M
YoY Change 321.01% -36.52%
NET CHANGE
Cash From Operating Activities 35.23M 28.86M
Cash From Investing Activities -6.348M -14.76M
Cash From Financing Activities -26.25M -6.234M
Net Change In Cash 1.603M 5.760M
YoY Change -72.17% -132.29%
FREE CASH FLOW
Cash From Operating Activities $35.23M $28.86M
Capital Expenditures $6.171M $13.95M
Free Cash Flow $29.06M $14.91M
YoY Change 94.86% -413.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000856982
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
South Jordan
CY2021Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
270754000
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
268894000
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
MERIT MEDICAL SYSTEMS INC
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55933000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55623000
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
0-18592
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0447695
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1600 West Merit Parkway
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84095
CY2021Q1 dei City Area Code
CityAreaCode
801
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
253-1600
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, no par
CY2021Q1 dei Trading Symbol
TradingSymbol
MMSI
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55997284
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58519000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56916000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5953000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5313000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
150314000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146641000
CY2021Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
8719000
CY2020Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
7774000
CY2021Q1 us-gaap Inventory Net
InventoryNet
200308000
CY2020Q4 us-gaap Inventory Net
InventoryNet
198019000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13617000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13120000
CY2021Q1 us-gaap Prepaid Taxes
PrepaidTaxes
3680000
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3688000
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3331000
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3549000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
438488000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
429707000
CY2021Q1 us-gaap Land
Land
28087000
CY2020Q4 us-gaap Land
Land
28400000
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
187774000
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
188878000
CY2021Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
61422000
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
61586000
CY2021Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
48319000
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
48800000
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
47735000
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
46889000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
644091000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
643447000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37676000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
265914000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
260719000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
378177000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382728000
CY2021Q1 us-gaap Goodwill
Goodwill
362500000
CY2020Q4 us-gaap Goodwill
Goodwill
363533000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4529000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4597000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
74714000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78240000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37286000
CY2021Q1 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
835054000
CY2020Q4 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
851961000
CY2021Q1 us-gaap Assets
Assets
1651719000
CY2020Q4 us-gaap Assets
Assets
1664396000
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
52986000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
49837000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
132173000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
111944000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12246000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12903000
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2773000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2820000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
207678000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
185004000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
312875000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
343722000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33252000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33312000
CY2021Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2021Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1016000
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1016000
CY2021Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
16227000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
16808000
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1896000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1923000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
67980000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70941000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33756000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52748000
CY2021Q1 us-gaap Liabilities
Liabilities
675027000
CY2020Q4 us-gaap Liabilities
Liabilities
705821000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-179000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55933000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55623000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
615113000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
606224000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
368761000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
357803000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7182000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5452000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
976692000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
958575000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1651719000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1664396000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248913000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243525000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137019000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
139741000
CY2021Q1 us-gaap Gross Profit
GrossProfit
111894000
CY2020Q1 us-gaap Gross Profit
GrossProfit
103784000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
81024000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78808000
CY2021Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
16274000
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14872000
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3845000
CY2021Q1 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-402000
CY2020Q1 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-4897000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
97700000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
102422000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14194000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1362000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
472000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
79000
CY2021Q1 us-gaap Interest Expense
InterestExpense
1537000
CY2020Q1 us-gaap Interest Expense
InterestExpense
3144000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-435000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-289000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1500000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3354000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12694000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1992000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1736000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1162000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10958000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55717000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55246000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56978000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55246000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10958000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
2921000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-7182000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
724000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-1849000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-4462000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-4125000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-535000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
7000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1730000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9465000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9228000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12619000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
958575000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10958000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1730000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3310000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5897000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
263000
CY2021Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
488000
CY2021Q1 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
93000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
976692000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
949944000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9465000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2641000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2369000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
371000
CY2020Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
866000
CY2020Q1 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
1467000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
939798000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10958000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21400000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23320000
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
28000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-37000
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
3925000
CY2021Q1 mmsi Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
3070000
CY2020Q1 mmsi Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
3134000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
402000
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4897000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
27000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
35000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
151000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
151000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3595000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2777000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5284000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3445000
CY2021Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
597000
CY2020Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-613000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3396000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4983000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1071000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3126000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-199000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2475000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-80000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
577000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4237000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4340000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5393000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1621000
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-174000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2109000
CY2021Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-581000
CY2020Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-789000
CY2021Q1 mmsi Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3151000
CY2020Q1 mmsi Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2945000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
56000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13950000
CY2021Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
24274000
CY2020Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
32018000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35232000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28864000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6171000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
692000
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1062000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
873000
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
250000
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
358000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6348000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14762000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5520000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1261000
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
9694000
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
30665000
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
40569000
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24540000
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
403000
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
12754000
CY2021Q1 mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
488000
CY2020Q1 mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
866000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26246000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6234000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1035000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2108000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1603000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5760000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56916000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44320000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58519000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50080000
CY2021Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
120000
CY2020Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
392000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1539000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
3198000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1660000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1637000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1688000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5383000
CY2020Q1 mmsi Fair Value Of Equity Investment In Exchange For Settlement Of Note Receivable
FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable
899000
CY2021Q1 mmsi Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement
StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement
2000
CY2020Q1 mmsi Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement
StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement
39000
CY2021Q1 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
93000
CY2020Q1 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
1467000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
131000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2800000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248913000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243525000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
120969000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
110933000
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
24750000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19308000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
54589000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
67778000
CY2021Q1 us-gaap Inventory Net
InventoryNet
200308000
CY2020Q4 us-gaap Inventory Net
InventoryNet
198019000
CY2020Q4 us-gaap Goodwill
Goodwill
363533000
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1033000
CY2021Q1 us-gaap Goodwill
Goodwill
362500000
CY2021Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12500000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000.0
CY2020Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
37320000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
48634000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
47454000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
44404000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
42548000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1700000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.137
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.583
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
375000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
403000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
320375000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
351222000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
312875000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
343722000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5625000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8438000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
11250000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
295437000
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320750000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10958000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55717000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55246000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55717000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55246000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1261000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56978000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55246000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1042000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4340000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3595000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2777000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248913000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243525000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14194000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1362000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1500000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3354000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1736000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1162000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
10958000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2020Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2020Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
3500000
CY2021Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12000000.0
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12000000.0
CY2021Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
359000
CY2021Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
2000000.0
CY2020Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
2200000
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
932000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
730000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
575000
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
202000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
95000
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
932000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
670000

Files In Submission

Name View Source Status
0000856982-21-000012-index-headers.html Edgar Link pending
0000856982-21-000012-index.html Edgar Link pending
0000856982-21-000012.txt Edgar Link pending
0000856982-21-000012-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmsi-20210331.xsd Edgar Link pending
mmsi-20210331ex10263fbb3.htm Edgar Link pending
mmsi-20210331ex1033446aa.htm Edgar Link pending
mmsi-20210331ex1040840b8.htm Edgar Link pending
mmsi-20210331ex10573f085.htm Edgar Link pending
mmsi-20210331ex31111580f.htm Edgar Link pending
mmsi-20210331ex3127ebcd3.htm Edgar Link pending
mmsi-20210331ex3216b674d.htm Edgar Link pending
mmsi-20210331ex32217c683.htm Edgar Link pending
mmsi-20210331x10q.htm Edgar Link pending
mmsi-20210331x10q001.jpg Edgar Link pending
mmsi-20210331x10q_htm.xml Edgar Link completed
mmsi-20210331_cal.xml Edgar Link unprocessable
mmsi-20210331_def.xml Edgar Link unprocessable
mmsi-20210331_lab.xml Edgar Link unprocessable
mmsi-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending